340B Drug Pricing Program
A Mississippi judge yesterday denied Novartis Pharmaceuticals’ and PhRMA’s request for a preliminary injunction against enforcement of state law protecting 340B pricing for contract pharmacy arrangements.
A Mississippi judge July 1 denied Novartis Pharmaceuticals’ and PhRMA’s request for a preliminary injunction against enforcement of state law protecting 340B pricing for contract pharmacy arrangements.
The AHA, 340B Health, the Maryland Hospital Association and the Mid-Atlantic Association of Community Health Centers yesterday filed an amicus brief in a federal district court in Maryland, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
The AHA, 340B Health, the Maryland Hospital Association and the Mid-Atlantic Association of Community Health Centers June 26 filed an amicus brief in a federal district court in Maryland, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
UNITED STATES DISTRICT COURTFOR THE DISTRICT OF MARYLAND
AHA, others file amicus brief in case to defend Mississippi’s 340B contract pharmacy law.
The AHA, along with 340B Health, the Mississippi Hospital Association and the Rural Hospital Alliance filed an amicus brief June 18 in the U.S. District Court for the Southern District of Mississippi, defending the state's law protecting 340B pricing for contract pharmacy arrangements.
UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF MISSISSIPPI NOVARTIS PHARMACEUTICALS CORPORATION, …
AHA 340B Advocacy Alliance Bulletin for June 18, 2024
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide Medicare incentive payments to hospitals.